Picture this.
A 2-year-old beagle named Chloe trots around an oval ramp in a lab outside Bengaluru.
Helmet on her head. Harness on her back. Cameras tracking every twitch.
She sniffs 72 human breath samples in under a minute.
Finds the one with cancer.
Runs to the chute. Collects her treat.
This is not a Black Mirror episode.
This is Dognosis — a Bengaluru startup that just raised $1.6 million to turn dogs into the world's most adorable cancer screening tool. 🐕
Dogs have 300 million olfactory receptors.
Humans? A measly 5-6 million.
We've known for almost two decades they can sniff out cancer, Covid, malaria, even Parkinson's — through volatile organic compounds in our breath.
In fact, trained dogs have hit detection rates as high as 97% on combined samples in past studies.
The problem was never the dog's nose.
It was us.
We couldn't reliably interpret what the dog was telling us.
Founders Itamar Bitan (ex-Israeli army canine bomb unit) and Akash Kulgod met on LinkedIn in 2023 and asked a strange question:
What if we stop trying to decode the smell… and start decoding the dog?
Every dog at Dognosis gets a digital twin called a Sniff Diary:
Machine learning then builds a personalized "tell" for each dog.
If Chloe pauses that way at station 7 — it's cancer.
Multiple dogs sniff the same sample. A grumpy dog's vote counts less. 🤯
Their pitch vs a PET CT scan?
Fasting, radiotracers, million-dollar magnets… or 10 minutes breathing into a mask.
Even with peer-reviewed proof, raising money was brutal.
80-100 VCs. Mostly rejections.
"Dogs can't be the future of medicine."
"Dogs can't scale."
But two backers loved "crazy sci-fi ideas" enough to write the cheque.
Next year, Dognosis plans to ship an at-home cancer screening kit — breathe into a mask, send it in, let the beagles do the rest.
A PET scanner costs crores.
A shelter dog costs dog food and belly rubs.
The future of cancer screening might not wear a lab coat.
It might just wag its tail.
That's all for now!
